Cabot Corporation (NYSE:CBT – Get Free Report)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as $65.59 and last traded at $67.15, with a volume of 38637 shares. The stock had previously closed at $67.56.
Wall Street Analysts Forecast Growth
CBT has been the topic of several recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Mizuho dropped their price target on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. Finally, UBS Group set a $82.00 price target on Cabot and gave the company a “neutral” rating in a report on Tuesday, August 5th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $85.00.
Read Our Latest Analysis on Cabot
Cabot Stock Performance
Cabot (NYSE:CBT – Get Free Report) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The company had revenue of $923.00 million for the quarter, compared to the consensus estimate of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Analysts expect that Cabot Corporation will post 7.57 EPS for the current year.
Insider Transactions at Cabot
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at $28,661,147.04. The trade was a 24.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.03% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Cabot
Institutional investors and hedge funds have recently modified their holdings of the stock. First Citizens Bank & Trust Co. grew its holdings in shares of Cabot by 144.4% during the 2nd quarter. First Citizens Bank & Trust Co. now owns 14,352 shares of the specialty chemicals company’s stock valued at $1,076,000 after acquiring an additional 8,479 shares in the last quarter. GAMMA Investing LLC raised its position in Cabot by 26.1% during the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock valued at $141,000 after acquiring an additional 352 shares in the last quarter. KBC Group NV raised its position in Cabot by 31.5% during the first quarter. KBC Group NV now owns 2,690 shares of the specialty chemicals company’s stock valued at $224,000 after acquiring an additional 644 shares in the last quarter. Park Avenue Securities LLC bought a new position in Cabot during the second quarter valued at approximately $312,000. Finally, PNC Financial Services Group Inc. raised its position in Cabot by 12.8% during the first quarter. PNC Financial Services Group Inc. now owns 4,356 shares of the specialty chemicals company’s stock valued at $362,000 after acquiring an additional 494 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
- Five stocks we like better than Cabot
 - Stock Analyst Ratings and Canadian Analyst Ratings
 - Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
 - How to Buy Gold Stock and Invest in Gold
 - ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
 - Stock Market Sectors: What Are They and How Many Are There?
 - Super Micro’s Moment of Truth: A Growth Story Under Pressure
 
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
